Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)

[41] Zimmerman GA(2003)PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme Circulation 108 92-96

[42] McIntyre TM(2005)Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction Diabetologia 48 2162-2169

[43] Wei Y(2007)The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity J Lipid Res 48 348-357

[44] Swenson L(2008)Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2) Biochemistry 47 8186-8194

[45] Castro C(1992)Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation Trans Assoc Am Physicians 105 44-63

[46] Derewenda U(1989)The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein Proc Natl Acad Sci USA 86 2393-2397

[47] Minor W(1997)Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma Eur J Clin Invest 27 595-602

[48] Arai H(2002)Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia J Lipid Res 43 256-263

[49] Derewenda ZS(2007)Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia Circulation 71 214-219

[50] Ho YS(2006)Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation Nephrol Dial Transplant 21 1270-1277

[41] Zimmerman GA(2003)PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme Circulation 108 92-96

[42] McIntyre TM(2005)Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction Diabetologia 48 2162-2169

[43] Wei Y(2007)The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity J Lipid Res 48 348-357

[44] Swenson L(2008)Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2) Biochemistry 47 8186-8194

[45] Castro C(1992)Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation Trans Assoc Am Physicians 105 44-63

[46] Derewenda U(1989)The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein Proc Natl Acad Sci USA 86 2393-2397

[47] Minor W(1997)Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma Eur J Clin Invest 27 595-602

[48] Arai H(2002)Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia J Lipid Res 43 256-263

[49] Derewenda ZS(2007)Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia Circulation 71 214-219

[50] Ho YS(2006)Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation Nephrol Dial Transplant 21 1270-1277